Abstract
Aim: To investigate the clinical use of a 670-nm diode red laser in the treatment of a number of retinal conditions. Methods: In all, 17 eyes of 17 patients were treated for conditions such as proliferative diabetic retinopathy, retinal neovascularization in central retinal vein occlusion, rhegmatogenous retinal lesions and retinal breaks, and prophylactic peripheral retinopexy prior to silicone oil removal after three port pars plana vitrectomy. Results: Regression of neovascularization was observed in all the eyes treated for vascular proliferation at the 3-month follow-up visit. Adhesive pigmented scars were observed in the remaining eyes 1 month after treatment. No major complications were recorded. Conclusions: In this pilot study, the 670-nm diode laser appears to be a promising modality for laser photocoagulation of the retina.
| Original language | English |
|---|---|
| Pages (from-to) | 171-174 |
| Number of pages | 4 |
| Journal | Eye (London, England) |
| Volume | 19 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2005 |
Fingerprint
Keywords
- Diode laser
- Retinal photocoagulation
ASJC Scopus subject areas
- Ophthalmology
- Sensory Systems
Cite this
Initial clinical experience using a diode red laser (670 nm) in the treatment of retinal disease. / Lanzetta, Paolo; Furlan, F.; Bandello, F.
In: Eye (London, England), Vol. 19, No. 2, 02.2005, p. 171-174.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Initial clinical experience using a diode red laser (670 nm) in the treatment of retinal disease
AU - Lanzetta, Paolo
AU - Furlan, F.
AU - Bandello, F.
PY - 2005/2
Y1 - 2005/2
N2 - Aim: To investigate the clinical use of a 670-nm diode red laser in the treatment of a number of retinal conditions. Methods: In all, 17 eyes of 17 patients were treated for conditions such as proliferative diabetic retinopathy, retinal neovascularization in central retinal vein occlusion, rhegmatogenous retinal lesions and retinal breaks, and prophylactic peripheral retinopexy prior to silicone oil removal after three port pars plana vitrectomy. Results: Regression of neovascularization was observed in all the eyes treated for vascular proliferation at the 3-month follow-up visit. Adhesive pigmented scars were observed in the remaining eyes 1 month after treatment. No major complications were recorded. Conclusions: In this pilot study, the 670-nm diode laser appears to be a promising modality for laser photocoagulation of the retina.
AB - Aim: To investigate the clinical use of a 670-nm diode red laser in the treatment of a number of retinal conditions. Methods: In all, 17 eyes of 17 patients were treated for conditions such as proliferative diabetic retinopathy, retinal neovascularization in central retinal vein occlusion, rhegmatogenous retinal lesions and retinal breaks, and prophylactic peripheral retinopexy prior to silicone oil removal after three port pars plana vitrectomy. Results: Regression of neovascularization was observed in all the eyes treated for vascular proliferation at the 3-month follow-up visit. Adhesive pigmented scars were observed in the remaining eyes 1 month after treatment. No major complications were recorded. Conclusions: In this pilot study, the 670-nm diode laser appears to be a promising modality for laser photocoagulation of the retina.
KW - Diode laser
KW - Retinal photocoagulation
UR - http://www.scopus.com/inward/record.url?scp=14644433795&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=14644433795&partnerID=8YFLogxK
U2 - 10.1038/sj.eye.6701440
DO - 10.1038/sj.eye.6701440
M3 - Article
C2 - 15218518
AN - SCOPUS:14644433795
VL - 19
SP - 171
EP - 174
JO - Eye
JF - Eye
SN - 0950-222X
IS - 2
ER -